Consequently, CHK inhibition can force p53-defective tumor cells to enter mitosis with unrepaired DNA damage, whereas p53-wild type containing non-tumor cells can overcome this stress by promoting the G1 checkpoint10,25. The gene discussed is TP53; the disease is neoplasm.